Safety and Immunogenicity Among Healthy Children Receiving Fluzone Influenza Virus Vaccine (2012-2013 Formulation).
Phase of Trial: Phase IV
Latest Information Update: 09 Jun 2014
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sanofi; sanofi pasteur
- 01 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 27 Sep 2012 New trial record